143 related articles for article (PubMed ID: 24913114)
21. Disappearance of immunoglobulins from persistent renal amyloid deposits following stem cell transplantation for heavy-and light-chain amyloidosis.
Safadi S; Saad A; Quint PS; Sethi S; Leung N; Kurtin P; Nasr SH
Nephrol Dial Transplant; 2015 Jul; 30(7):1151-5. PubMed ID: 25796445
[TBL] [Abstract][Full Text] [Related]
22. Systemic immunoglobulin light-chain amyloidosis (AL) in Mexico: a single institution, 30-year experience.
Hernández-Reyes J; Galo-Hooker E; Ruiz-Delgado GJ; Ruiz-Argüelles GJ
Rev Invest Clin; 2012; 64(6 Pt 2):604-8. PubMed ID: 23593777
[TBL] [Abstract][Full Text] [Related]
23. Multisystem amyloidosis as the unifying diagnosis for constipation, collapse and cardiomyopathy.
McFarlane M; Bashford A; Sah S; Disney BR
BMJ Case Rep; 2018 Jul; 2018():. PubMed ID: 29991549
[TBL] [Abstract][Full Text] [Related]
24. Oral amyloidosis: a late complication of multiple myeloma.
Salisbury PL; Jacoway JR
Oral Surg Oral Med Oral Pathol; 1983 Jul; 56(1):48-50. PubMed ID: 6576310
[TBL] [Abstract][Full Text] [Related]
25. Monoclonal immunoglobulin deposition disease: light chain and light and heavy chain deposition diseases and their relation to light chain amyloidosis. Clinical features, immunopathology, and molecular analysis.
Buxbaum JN; Chuba JV; Hellman GC; Solomon A; Gallo GR
Ann Intern Med; 1990 Mar; 112(6):455-64. PubMed ID: 2106817
[TBL] [Abstract][Full Text] [Related]
26. The clinical spectrum of light chain myeloma. A study of 35 patients with special reference to the occurrence of amyloidosis.
Stone MJ; Frendel EP
Am J Med; 1975 May; 58(5):601-19. PubMed ID: 1130419
[TBL] [Abstract][Full Text] [Related]
27. Cutaneous light chain amyloidosis with multiple myeloma: A concise review.
Andrei M; Wang JC
Hematol Oncol Stem Cell Ther; 2019 Jun; 12(2):71-81. PubMed ID: 30261180
[TBL] [Abstract][Full Text] [Related]
28. Head and neck amyloidosis: clinicopathological features and immunohistochemical analysis of 14 cases.
Gouvêa AF; Ribeiro AC; León JE; Carlos R; de Almeida OP; Lopes MA
J Oral Pathol Med; 2012 Feb; 41(2):178-85. PubMed ID: 21883489
[TBL] [Abstract][Full Text] [Related]
29. Exceptional oral manifestations of amyloid light chain protein (AL) systemic amyloidosis.
Elad S; Czerninski R; Fischman S; Keshet N; Drucker S; Davidovich T; Goldschmidt N
Amyloid; 2010 Mar; 17(1):27-31. PubMed ID: 20146645
[TBL] [Abstract][Full Text] [Related]
30. A patient with multiple myeloma, amyloidosis and light-chain deposition disease in kidneys with a long survival.
Christou L; Hatzimichael EC; Sotsiou-Candila F; Siamopoulos K; Bourantas KL
Acta Haematol; 1999; 101(4):202-5. PubMed ID: 10436302
[TBL] [Abstract][Full Text] [Related]
31. AL amyloidosis or multiple myeloma? An important distinction--response to Falk.
Dinner S; Liedtke M
Br J Haematol; 2014 Mar; 164(5):749-50. PubMed ID: 24344936
[No Abstract] [Full Text] [Related]
32. Massive systemic amyloidosis associated with light-chain deposition disease.
Troussard X; Hurault de Ligny B; Gallet B; Ganeval D; Mandard JC; Ryckelynck JP; Leporrier M
Nephron; 1989; 52(2):139-43. PubMed ID: 2500613
[TBL] [Abstract][Full Text] [Related]
33. Clinical manifestations at diagnosis in Japanese patients with systemic AL amyloidosis: a retrospective study of 202 cases with a special attention to uncommon symptoms.
Matsuda M; Katoh N; Ikeda S
Intern Med; 2014; 53(5):403-12. PubMed ID: 24583427
[TBL] [Abstract][Full Text] [Related]
34. Preferential expression of human lambda-light-chain variable-region subgroups in multiple myeloma, AL amyloidosis, and Waldenström's macroglobulinemia.
Ozaki S; Abe M; Wolfenbarger D; Weiss DT; Solomon A
Clin Immunol Immunopathol; 1994 May; 71(2):183-9. PubMed ID: 8181187
[TBL] [Abstract][Full Text] [Related]
35. The diagnosis and characteristics of renal heavy-chain and heavy/light-chain amyloidosis and their comparison with renal light-chain amyloidosis.
Nasr SH; Said SM; Valeri AM; Sethi S; Fidler ME; Cornell LD; Gertz MA; Dispenzieri A; Buadi FK; Vrana JA; Theis JD; Dogan A; Leung N
Kidney Int; 2013 Mar; 83(3):463-70. PubMed ID: 23302715
[TBL] [Abstract][Full Text] [Related]
36. Light chain type predicts organ involvement and survival in AL amyloidosis patients receiving stem cell transplantation.
Sidiqi MH; Aljama MA; Muchtar E; Buadi FK; Warsame R; Lacy MQ; Dispenzieri A; Dingli D; Leung N; Gonsalves WI; Kumar SK; Kapoor P; Kourelis TV; Hogan WJ; Gertz MA
Blood Adv; 2018 Apr; 2(7):769-776. PubMed ID: 29615413
[TBL] [Abstract][Full Text] [Related]
37. [Bilateral pleurisy revealing a myelome with free light chains complicated with an osseous amylose].
El Boukhrissi F; Balouch L; Hachimi MA; Hommadi A; Idrissi MM; Bamou Y
Ann Biol Clin (Paris); 2011; 69(5):593-6. PubMed ID: 22008141
[TBL] [Abstract][Full Text] [Related]
38. Rapid Deterioration of the Renal Function Caused by the Coexistence of Intratubular Amyloidosis and Myeloma Cast Nephropathy.
Kato H; Fujigaki Y; Asakawa S; Yamaguchi Y; Uozaki H; Komatsuda A; Nagata M; Uchida S
Intern Med; 2015; 54(23):3023-8. PubMed ID: 26631886
[TBL] [Abstract][Full Text] [Related]
39. [Complete remission of nephrotic syndrome and improvement of renal function in a patient with light chain deposition disease following high dose chemotherapy with transplantation of autologous haematopoietic stem cells. A case study and review of literature].
Adam Z; Krejcí M; Pour L; Stepánková S; Cermáková Z; Voska L; Teplan V; Krivanová A; Hájek R; Mayer J
Vnitr Lek; 2009 Nov; 55(11):1089-96. PubMed ID: 20017442
[TBL] [Abstract][Full Text] [Related]
40. AL amyloidosis or multiple myeloma? An important distinction.
Falk RH
Br J Haematol; 2014 Mar; 164(5):748-9. PubMed ID: 24261595
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
